{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:15:27Z","timestamp":1684469727671},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1038\/sj.bjc.6603289","type":"journal-article","created":{"date-parts":[[2006,8,15]],"date-time":"2006-08-15T10:47:06Z","timestamp":1155638826000},"page":"470-474","source":"Crossref","is-referenced-by-count":1,"title":["Multicenter phase II trial of accelerated cisplatin and high-dose epirubicin followed by surgery or radiotherapy in patients with stage IIIa non-small-cell lung cancer with mediastinal lymph node involvement (N2-disease)"],"prefix":"10.1038","volume":"95","author":[{"given":"E C J","family":"Phernambucq","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Biesma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E F","family":"Smit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M A","family":"Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A vd","family":"Tol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F M","family":"Schramel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R J","family":"Bolhuis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P E","family":"Postmus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,8,8]]},"reference":[{"issue":"Suppl 2","key":"BF6603289_CR1","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/S0959-8049(05)80281-3","volume":"29A","author":"R Abels","year":"1993","unstructured":"Abels R (1993) Erythropoietin for anaemia in cancer patients. Eur J Cancer 29A (Suppl 2): S2\u2013S8","journal-title":"Eur J Cancer"},{"key":"BF6603289_CR2","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0003-4975(01)03257-X","volume":"73","author":"T Akhurst","year":"2002","unstructured":"Akhurst T, Downey RJ, Ginsberg MS, Gonen M, Bains M, Korst R, Ginsberg RJ, Rusch VW, Larson SM (2002) An initial experience with FDG-PET in the imaging of residual disease after induction therapy for lung cancer. Ann Thorac Surg 73: 259\u2013264","journal-title":"Ann Thorac Surg"},{"key":"BF6603289_CR3","doi-asserted-by":"publisher","first-page":"624s","DOI":"10.1200\/jco.2005.23.16_suppl.7014","volume":"23","author":"KS Albain","year":"2005","unstructured":"Albain KS, Schwann RS, Rusch VR, Turrisi AT, Shepherd FA, Smith CJ, Gandara DR, Johnson DH, Green MR, Miller RC (2005) Phase III study of concurrent chemotherapy and full course radiotherapy (CT\/RT) versus CT\/RT induction followed by surgical resection for stage IIIa(pN2) non-small cell lung cancer (NSCLC); first outcome analysis of North American Intergroup trial 0139 (RTOG 93\u201309). J Clin Oncol 23: 624s","journal-title":"J Clin Oncol"},{"key":"BF6603289_CR4","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1001\/jama.294.8.931","volume":"294","author":"JT Annema","year":"2005","unstructured":"Annema JT, Versteegh MI, Veselic M, Welker L, Mauad T, Sont JK, Willems LN, Rabe KF (2005) Endoscopic ultrasound added to mediastinoscopy for preoperative staging of patients with lung cancer. JAMA 294: 931\u2013936","journal-title":"JAMA"},{"key":"BF6603289_CR5","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1200\/JCO.2003.11.040","volume":"21","author":"DC Betticher","year":"2003","unstructured":"Betticher DC, Hsu Schmitz SF, Totsch M, Hansen E, Joss C, von Briel C, Schmid RA, Pless M, Habicht J, Roth AD, Spiliopoulos A, Stahel R, Weder W, Stupp R, Egli F, Furrer M, Honegger H, Wernli M, Cerny T, Ris HB (2003) Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial. J Clin Oncol 21: 1752\u20131759","journal-title":"J Clin Oncol"},{"key":"BF6603289_CR6","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1016\/S0003-4975(00)01585-X","volume":"70","author":"R Bueno","year":"2000","unstructured":"Bueno R, Richards WG, Swanson SJ, Jaklitsch MT, Lukanich JM, Mentzer SJ, Sugarbaker DJ (2000) Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival. Ann Thorac Surg 70: 1826\u20131831","journal-title":"Ann Thorac Surg"},{"key":"BF6603289_CR7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.lungcan.2004.06.004","volume":"47","author":"RL Burkes","year":"2005","unstructured":"Burkes RL, Shepherd FA, Blackstein ME, Goldberg ME, Waters PF, Patterson GA, Todd T, Pearson FG, Jones D, Farooq S, McGlaughlin J, Ginsberg RJ (2005) Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage IIIA (T1\u20133, N2) unresectable non-small-cell lung cancer: final results of the Toronto phase II trial. Lung Cancer 47: 103\u2013109","journal-title":"Lung Cancer"},{"key":"BF6603289_CR8","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0169-5002(03)00365-9","volume":"42","author":"F Cappuzzo","year":"2003","unstructured":"Cappuzzo F, De Marinis F, Nelli F, Calandri C, Maestri A, Benedetti G, Migliorino MR, Cortesi E, Rastelli F, Martelli O, Andruccetti M, Bartolini S, Crino L (2003) Phase II study of gemcitabine-cisplatin-paclitaxel triplet as induction chemotherapy in inoperable, locally-advanced non-small cell lung cancer. Lung Cancer 42: 355\u2013361","journal-title":"Lung Cancer"},{"key":"BF6603289_CR9","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1159\/000227501","volume":"52","author":"S Cascinu","year":"1995","unstructured":"Cascinu S, Del Ferro E, Fedeli A, Ligi M, Alessandroni P, Catalano G (1995) Recombinant human erythropoietin treatment in elderly cancer patients with cisplatin-associated anemia. Oncology 52: 422\u2013426","journal-title":"Oncology"},{"key":"BF6603289_CR10","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/S1010-7940(99)00082-2","volume":"15","author":"P De Leyn","year":"1999","unstructured":"De Leyn P, Vansteenkiste J, Deneffe G, Van Raemdonck D, Coosemans W, Lerut T (1999) Result of induction chemotherapy followed by surgery in patients with stage IIIA N2 NSCLC: importance of pre-treatment mediastinoscopy. Eur J Cardiothorac Surg 15: 608\u2013614","journal-title":"Eur J Cardiothorac Surg"},{"key":"BF6603289_CR11","doi-asserted-by":"publisher","first-page":"3412","DOI":"10.1200\/JCO.1998.16.10.3412","volume":"16","author":"GD Demetri","year":"1998","unstructured":"Demetri GD, Kris M, Wade J, Degos L, Cella D (1998) Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group. J Clin Oncol 16: 3412\u20133425","journal-title":"J Clin Oncol"},{"key":"BF6603289_CR12","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1200\/JCO.1997.15.3.1218","volume":"15","author":"J Glaspy","year":"1997","unstructured":"Glaspy J, Bukowski R, Steinberg D, Taylor C, Tchekmedyian S, Vadhan-Raj S (1997) Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group. J Clin Oncol 15: 1218\u20131234","journal-title":"J Clin Oncol"},{"key":"BF6603289_CR13","doi-asserted-by":"publisher","first-page":"8362","DOI":"10.1200\/JCO.2005.01.1189","volume":"23","author":"CJ Hoekstra","year":"2005","unstructured":"Hoekstra CJ, Stroobants SG, Smit EF, Vansteenkiste J, Van Tinteren H, Postmus PE, Golding RP, Biesma B, Schramel FJHM, Van Zandwijk N, Lammertsma AA, Hoekstra OS (2005) Prognostic relevance of response evaluation using [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with locally advanced non-small-cell lung cancer. J Clin Oncol 23: 8362\u20138370","journal-title":"J Clin Oncol"},{"key":"BF6603289_CR14","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1054\/bjoc.2001.2013","volume":"85","author":"C Huisman","year":"2001","unstructured":"Huisman C, Biesma B, Postmus PE, Giaccone G, Schramel FM, Smit EF (2001) Accelerated cisplatin and high-dose epirubicin with G-CSF support in patients with relapsed non-small-cell lung cancer: feasibility and efficacy. Br J Cancer 85: 1456\u20131461","journal-title":"Br J Cancer"},{"key":"BF6603289_CR15","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"E Kaplan","year":"1958","unstructured":"Kaplan E, Meier P (1958) Non-parametric estimation from incomplete observations. J Am Stat Assoc 53: 457\u2013481","journal-title":"J Am Stat Assoc"},{"key":"BF6603289_CR16","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/nrc1650","volume":"5","author":"JJ Kim","year":"2005","unstructured":"Kim JJ, Tannock IF (2005) Repopulation of cancer cells during therapy: an important cause of treatment failure. Nat Rev Cancer 5: 516\u2013525","journal-title":"Nat Rev Cancer"},{"key":"BF6603289_CR17","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/00004728-200001000-00007","volume":"24","author":"KS Lee","year":"2000","unstructured":"Lee KS, Shim YM, Han J, Kim J, Ahn YC, Park K, Jung KJ (2000) Primary tumors and mediastinal lymph nodes after neoadjuvant concurrent chemoradiotherapy of lung cancer: serial CT findings with pathologic correlation. J Comput Assist Tomogr 24: 35\u201340","journal-title":"J Comput Assist Tomogr"},{"key":"BF6603289_CR18","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/S1010-7940(01)00697-2","volume":"19","author":"S Margaritora","year":"2001","unstructured":"Margaritora S, Cesario A, Galetta D, D'Andrilli A, Macis G, Mantini G, Trodella L, Granone P (2001) Ten year experience with induction therapy in locally advanced non-small cell lung cancer (NSCLC): is clinical re-staging predictive of pathological staging? Eur J Cardiothorac Surg 19: 894\u2013898","journal-title":"Eur J Cardiothorac Surg"},{"key":"BF6603289_CR19","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/S0003-4975(03)01457-7","volume":"77","author":"JL Port","year":"2004","unstructured":"Port JL, Kent MS, Korst RJ, Keresztes R, Levin MA, Altorki NK (2004) Positron emission tomography scanning poorly predicts response to preoperative chemotherapy in non-small cell lung cancer. Ann Thorac Surg 77: 254\u2013259","journal-title":"Ann Thorac Surg"},{"key":"BF6603289_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0169-5002(99)00045-8","volume":"26","author":"R Rosell","year":"1999","unstructured":"Rosell R, Gomez-Codina J, Camps C, Javier SJ, Maestre J, Padilla J, Canto A, Abad A, Roig J (1999) Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial. Lung Cancer 26: 7\u201314","journal-title":"Lung Cancer"},{"key":"BF6603289_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0169-5002(98)00046-4","volume":"21","author":"JA Roth","year":"1998","unstructured":"Roth JA, Atkinson EN, Fossella F, Komaki R, Bernadette RM, Putnam Jr JB, Lee JS, Dhingra H, De Caro L, Chasen M, Hong WK (1998) Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. Lung Cancer 21: 1\u20136","journal-title":"Lung Cancer"},{"key":"BF6603289_CR22","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1016\/j.ejca.2005.03.024","volume":"41","author":"JH Savonije","year":"2005","unstructured":"Savonije JH, van Groeningen CJ, van Bochove A, Honkoop AH, van Felius CL, Wormhoudt LW, Giaccone G (2005) Effects of early intervention with epoetin alfa on transfusion requirement, hemoglobin level and survival during platinum-based chemotherapy: Results of a multicenter randomised controlled trial. Eur J Cancer 41: 1560\u20131569","journal-title":"Eur J Cancer"},{"key":"BF6603289_CR23","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0169-5002(03)00245-9","volume":"42","author":"N Sawabata","year":"2003","unstructured":"Sawabata N, Keller SM, Matsumura A, Kawashima O, Hirono T, Osaka Y, Maeda H, Fukai S, Kawahara M (2003) The impact of residual multi-level N2 disease after induction therapy for non-small cell lung cancer. Lung Cancer 42: 69\u201377","journal-title":"Lung Cancer"},{"key":"BF6603289_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0197-2456(89)90015-9","volume":"10","author":"R Simon","year":"1989","unstructured":"Simon R (1989) Optimal two-stage designs for phase II clinical trials. Control Clin Trials 10: 1\u201310","journal-title":"Control Clin Trials"},{"key":"BF6603289_CR25","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","volume":"92","author":"P Therasse","year":"2000","unstructured":"Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92: 205\u2013216","journal-title":"J Natl Cancer Inst"},{"key":"BF6603289_CR26","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1016\/S0169-5002(03)91931-3","volume":"41","author":"JP Van Meerbeeck","year":"2003","unstructured":"Van Meerbeeck JP, Kramer G, Van Schil PEY, Legrand C, O'Brien M, Manegold C, Giaccone G, Van Zandwijk N, Splinter TAW (2003) Induction chemotherapy (CT) in stage IIIA-N2 non-small cell lung cancer (NSCLC): an analysis of different regimens used in EORTC 08941. Lung cancer 41: S79\u2013S80","journal-title":"Lung cancer"},{"key":"BF6603289_CR27","doi-asserted-by":"publisher","first-page":"1095s","DOI":"10.1200\/JCO.20005.14.589","volume":"23","author":"JP Van Meerbeeck","year":"2005","unstructured":"Van Meerbeeck JP, Kramer G, Van Schil PE, Legrand C, Smit EF, Schramel FM, Biesma B, Tjan-Heijnen VC, Van Zandwijk N, Giaccone G (2005) A randomized trial of radical surgery (S) versus thoracic radiotherapy (TRT) in patients (pts) with stage IIIA-N2 non-small cell lung cancer (NSCLC) after response to induction chemotherapy (ICT) (EORTC 08941). J Clin Oncol 23: 1095s","journal-title":"J Clin Oncol"},{"key":"BF6603289_CR28","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1200\/JCO.2000.18.14.2658","volume":"18","author":"N Van Zandwijk","year":"2000","unstructured":"Van Zandwijk N, Smit EF, Kramer GW, Schramel F, Gans S, Festen J, Termeer A, Schlosser NJ, Debruyne C, Curran D, Giaccone G (2000) Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955). J Clin Oncol 18: 2658\u20132664","journal-title":"J Clin Oncol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6603289.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6603289","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6603289.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:22:39Z","timestamp":1684412559000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6603289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["BF6603289"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6603289","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}